Castelnuovo Berardenga, Italy

Michele Pellegrini

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michele Pellegrini: Innovator in Pediatric Vaccines

Introduction

Michele Pellegrini is a notable inventor based in Castelnuovo Berardenga, Italy. He has made significant contributions to the field of immunology, particularly in the development of vaccines for pediatric use. With a total of two patents to his name, Pellegrini's work focuses on enhancing the immune responses in children against influenza viruses.

Latest Patents

Pellegrini's latest patents revolve around adjuvanted influenza vaccines specifically designed for pediatric populations. These vaccines utilize a sub-micron oil-in-water emulsion that elicits significantly higher immune responses compared to existing unadjuvanted pediatric influenza vaccines. The adjuvanted vaccines are shown to induce a longer persistence of high serum antibody titers in children, as well as longer seroconversion and seroprotection. The improvements in immune responses are particularly notable for influenza B virus strains. Furthermore, while the existing vaccine provides inadequate immunity in children after a single dose, Pellegrini's adjuvanted vaccine demonstrates high seroprotection rates against the influenza A virus H3N2 subtype even after just one dose. Additionally, it offers significantly better seroprotection against mismatched strains of influenza A virus.

Career Highlights

Throughout his career, Michele Pellegrini has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Seqirus UK Limited. His experience in these organizations has contributed to his expertise in vaccine development and immunology.

Collaborations

Pellegrini has collaborated with notable professionals in his field, including Audino Podda and Nicola Groth. These collaborations have likely enriched his research and development efforts in pediatric vaccines.

Conclusion

Michele Pellegrini's innovative work in the development of adjuvanted influenza vaccines for children represents a significant advancement in pediatric immunization. His contributions are poised to improve the health outcomes of children worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…